Pàgina inicial > Resultats de la cerca: Thum, Thomas
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 5 registres trobats en 0.02 segons.
Articles, 5 registres trobats
Articles 5 registres trobats  
1.
8 p, 1.1 MB Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity / Chatterjee, Shambhabi (Institute of Molecular and Translational Therapeutic Strategies (IMTTS). Hannover Medical School) ; Gonzalo Calvo, David de (Institut d'Investigació Biomèdica Sant Pau) ; Derda, Anselm A. (Hannover Medical School. Department of Cardiology and Angiology) ; Schimmel, Katharina (Institute of Molecular and Translational Therapeutic Strategies (IMTTS). Hannover Medical School) ; Sonnenschein, Kristina (Hannover Medical School. Department of Cardiology and Angiology) ; Bavendiek, Udo (Hannover Medical School. Department of Cardiology and Angiology) ; Bauersachs, Johann (REBIRTH Excellence Cluster. Hannover Medical School) ; Bär, Christian (Institute of Molecular and Translational Therapeutic Strategies (IMTTS). Hannover Medical School) ; Thum, Thomas (National Heart and Lung Institute. Imperial College London)
Telomere length is a marker of biological aging. Short leukocyte telomere length has been associated with various conditions including cardiovascular disorders. Here, we evaluated if patients with hypertrophic cardiomyopathy have altered leukocyte telomere length and whether this is associated with disease severity. [...]
2018 - 10.1038/s41598-018-29072-8
Scientific reports, Vol. 8 Núm. 1 (january 2018) , p. 11227  
Registre complet - Creative Commons
2.
8 p, 1.1 MB Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy / Sonnenschein, Kristina (Hannover Medical School. Department of Cardiology and Angiology) ; Wilczek, Adriana Luisa (Institute of Molecular and Translational Therapeutic Strategies (IMTTS). Hannover Medical School) ; Gonzalo Calvo, David de (Institut d'Investigació Biomèdica Sant Pau) ; Pfanne, Angelika (Institute of Molecular and Translational Therapeutic Strategies (IMTTS). Hannover Medical School) ; Derda, Anselm Arthur (Hannover Medical School. Department of Cardiology and Angiology) ; Zwadlo, Carolin (Hannover Medical School. Department of Cardiology and Angiology) ; Bavendiek, Udo (Hannover Medical School. Department of Cardiology and Angiology) ; Bauersachs, Johann (REBIRTH Center of Translational Regenerative Medicine. Hannover Medical School) ; Fiedler, Jan (Institute of Molecular and Translational Therapeutic Strategies (IMTTS). Hannover Medical School) ; Thum, Thomas (REBIRTH Center of Translational Regenerative Medicine. Hannover Medical School)
Hypertrophic cardiomyopathy (HCM) is one of the most common hereditary heart diseases and is associated with a high risk of sudden cardiac death. HCM is characterized by pronounced hypertrophy of cardiomyocytes, fiber disarray and development of fibrosis and can be divided into a non-obstructive (HNCM) and obstructive form (HOCM) therefore requiring personalized therapeutic therapies. [...]
2019 - 10.1038/s41598-019-56617-2
Scientific reports, Vol. 9 Núm. 1 (january 2019) , p. 20350  
Registre complet - Creative Commons
3.
50 p, 1.3 MB CARDIOVASCULAR RNA MARKERS AND ARTIFICIAL INTELLIGENCE MAY IMPROVE COVID-19 OUTCOME : POSITION PAPER FROM THE EU-CardioRNA COST Action CA17129 / Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Robinson, Emma L. (Maastricht University) ; Jusic, Amela (Cardiovascular Research Unit) ; Carpusca, Irina (Cardiovascular Research Unit) ; de Windt, Leon J.. (Department of Molecular Genetics) ; Emanueli, Costanza (National Heart & Lung Institute) ; Ferdinandy, Péter (Cardiometabolic Research Group and MTA-SE System Pharmacology Research Group) ; Gu, Wei (Luxembourg Center for Systems Biomedicine) ; Gyöngyösi, Mariann (Department of Cardiology) ; Hackl, Matthias (TAmiRNA GmbH) ; Karaduzovic-Hadziabdic, Kanita (Faculty of Engineering and Natural Sciences) ; Lustrek, Mitja (Department of Intelligent Systems) ; Martelli, Fabio (Molecular Cardiology Laboratory) ; Nham, Eric (University of Zagreb School of Medicine) ; Potočnjak, Ines (Institute for Clinical Medical Research and Education) ; Satagopam, Venkata (Luxembourg Center for Systems Biomedicine) ; Schneider, Reinhard (Luxembourg Center for Systems Biomedicine) ; Thum, Thomas (Institute of Molecular and Translational Therapeutic Strategies (IMTTS)) ; Devaux, Yvan (Cardiovascular Research Unit) ; Universitat Autònoma de Barcelona
The coronavirus disease 2019 (COVID-19) pandemic has been as unprecedented as unexpected, affecting more than 105 million people worldwide as of February 8th, 2020 and causing more than 2. 3 million deaths according the World Health Organization. [...]
2021 - 10.1093/cvr/cvab094
Cardiovascular research, april 2021  
Registre complet - Creative Commons
4.
9 p, 1.2 MB Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction : A cardiovascular magnetic resonance study / Gonzalo Calvo, David de (Institut d'Investigació Biomèdica Sant Pau) ; Cediel, Germán (Universitat Autònoma de Barcelona. Departament de Medicina) ; Bär, Christian (Hannover Medical School. Institute of Molecular and Translational Therapeutic Strategies) ; Núñez, Julio (Hospital Clínic Universitari (València)) ; Revuelta-Lopez, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gavara Doñate, Jose (Universidad Politécnica de Madrid) ; Ríos-Navarro, César (Hospital Clínic Universitari (València)) ; Llorente-Cortes, Vicenta (Institut d'Investigació Biomèdica Sant Pau) ; Bodi, Vicente (Hospital Clínic Universitari (València)) ; Thum, Thomas (Imperial College London. National Heart and Lung Institute) ; Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina)
Reliable noninvasive prognostic biomarkers for left ventricular (LV) remodeling in ST-segment elevation myocardial infarction (STEMI) are needed. This study aimed to evaluate a panel of circulating microRNAs (miRNAs) as biomarkers of LV remodeling using cardiovascular magnetic resonance (CMR). [...]
2018 - 10.1038/s41598-018-33491-y
Scientific reports, Vol. 8 (october 2018)  
Registre complet - Creative Commons
5.
18 p, 5.7 MB Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) / de Boer, Rudolf A.. (University Medical Center Groningen) ; Hulot, Jean-Sébastien (Université de Paris) ; Tocchetti, Carlo Gabriele (Federico II University) ; Aboumsallem, Joseph Pierre (University Medical Center Groningen) ; Ameri, Pietro (University of Genova. Department of Internal Medicine) ; Anker, Stefan D. (Charité - Universitätsmedizin Berlin) ; Bauersachs, Johann (Hannover Medical School) ; Bertero, Edoardo (University Clinic Würzburg) ; Coats, Andrew J. S. (San Raffaele Pisana Scientific Institute) ; Čelutkienė, Jelena (Vilnius University) ; Chioncel, O. (University of Medicine Carol Davila) ; Dodion, Pierre (Innate Pharma) ; Eschenhagen, Thomas (University Medical Center Hamburg. Institute of Experimental Pharmacology and Toxicology) ; Farmakis, D. (University of Cyprus Medical School) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Jäger, Dirk (Heidelberg University Hospital (Alemanya)) ; Jankowska, Ewa A. (Wroclaw Medical University. Department of Heart Diseases) ; Kitsis, Richard N. (Albert Einstein College of Medicine) ; Konety, Suma H. (University of Minnesota Medical School) ; Larkin, James (Royal Marsden NHS Foundation Trust) ; Lehmann, Lorenz (University of Heidelberg. Department of Cardiology) ; Lenihan, Daniel J. (Washington University in St. Louis) ; Maack, Christoph (University Clinic Würzburg) ; Moslehi, Javid J. (Vanderbilt University Medical Center) ; Müller, Oliver J. (University of Kiel. Department of Internal Medicine) ; Nowak-Sliwinska, Patrycja (University of Geneva. Institute of Pharmaceutical Sciences of Western Switzerland) ; Piepoli, Massimo Francesco (University of Parma) ; Ponikowski, Piotr (Wroclaw Medical University. Department of Heart Diseases) ; Pudil, Radek (University Hospital and Medical Faculty (Czech Republic)) ; Rainer, Peter P. (7 Medical University of Graz) ; Ruschitzka, Frank (University Hospital Zurich (Suïssa)) ; Sawyer, Douglas (Maine Medical Center) ; Seferovic, Petar M. (University of Belgrade) ; Suter, Thomas (Bern University) ; Thum, Thomas (Hannover Medical School) ; van der Meer, Peter (University Medical Center Groningen) ; Van Laake, Linda W. (Utrecht University) ; von Haehling, Stephan (University of Göttingen Medical Center. Department of Cardiology and Pneumology) ; Heymans, Stephane (Maastricht University. Department of Cardiology) ; Lyon, Alexander R. (Imperial College London. National Heart and Lung Institute) ; Backs, Johannes (Heidelberg University Hospital (Alemanya)) ; Universitat Autònoma de Barcelona. Departament de Medicina
The co-occurrence of cancer and heart failure (HF) represents a significant clinical drawback as each disease interferes with the treatment of the other. In addition to shared risk factors, a growing body of experimental and clinical evidence reveals numerous commonalities in the biology underlying both pathologies. [...]
2020 - 10.1002/ejhf.2029
European Journal of Heart Failure, Vol. 22 (november 2020) , p. 2272-2289  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
1 Thum, T.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem